Flu influenza vaccine market is anticipated to grow at a CAGR of 6.9% during the forecast period. Seasonal influenza or flu is an acute respiratory infection caused by influenza viruses and is commonly categorized into 4 types such as types A, B, C, and D. The influenza virus causes regional epidemics and outbreaks, resulting in thousands of mortalities annually. Globally, the flu influenza pandemic is estimated to result in about 3 to 5 million cases of severe illness, and about 290 000 to 650 000 respiratory deaths, as per WHO. In addition, 99% of mortalities in children under 5 years of age with influenza-related lower respiratory tract infections are found in developing countries. Owing to increased prevalence, the development and production of flu influenza vaccines are also surging, leading to market growth. Organizations such as World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and other government authorities are creating awareness and assisting the population to fight against the virus by getting vaccinated. To provide maximum protection against diseases, the supply and demand for flu influenza vaccines have surged.
Get Free Sample link @ https://www.omrglobal.com/request-sample/flu-influenza-vaccine-market
Moreover, an increase in investment by prominent market players and a rise in government support and initiatives such as awareness camps and programs have accelerated the launch of therapeutically effective vaccines which in turn, is driving the global influenza vaccine market growth. However, delays in regulatory approvals for clinical trials may delay the development of vaccines which limits the growth of the market. Major players are investing in R&D facilities to increase their production with advanced technology, which is expected to offer lucrative growth opportunities. For instance, in February 2022, the Seqirus business of CSL Limited invested in a new research and development facility located in Waltham, Mass. The new facility will support the company’s growing R&D portfolio, with a focus on a self-amplifying messenger RNA (sa-mRNA) technology platform, the next generation of mRNA technology. The facility will serve as the company’s central R&D hub for current and future vaccine design, and collaboration with stakeholders from across the industry and academia.
A full report of Flu Influenza Vaccine Market available @ https://www.omrglobal.com/industry-reports/flu-influenza-vaccine-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Flu Influenza Vaccine Market by Vaccine Type
- Quadrivalent
- Trivalent
Global Flu Influenza Vaccine Market by Technology
- Egg-Based
- Cell Culture
Global Flu Influenza Vaccine Market by Age Group
- Pediatric
- Adult
Global Flu Influenza Vaccine Market by Route of Administration
- Injection
- Nasal Spray
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Abbott Laboratories
- AstraZeneca plc
- Biodiem
- CPL Biologicals Pvt. Ltd
- CSL Limited (Seqirus GmbH)
- Emergent BioSolutions
- Hoffmann-La Roche Ltd.
- Gamma Vaccines Pty Ltd.
- GlaxoSmithKline plc
- MedImmune LLC (AstraZeneca plc)
- Merck & Co. Inc. (Merck Sharp & Dohme Corp.)
- Mitsubishi Tanabe Pharma Corporation
- Novartis International AG
- Pfizer Inc.
- Sanofi S.A.
- Sinovac Biotech Ltd.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global flu influenza vaccine market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/flu-influenza-vaccine-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
